Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01920139 · ClinicalTrials.gov registry record · NA
Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy
A NA study of Focus: Breast Cancer With Axillary Node Metastasis, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT01920139: Completed NA study of Focus: Breast Cancer With Axillary Node Metastasis, sponsored by University of Pittsburgh.
NCT01920139 is a NA study of Focus: Breast Cancer With Axillary Node Metastasis that has completed, run by University of Pittsburgh. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01920139, a NA study of Focus: Breast Cancer With Axillary Node Metastasis, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The study was performed to determine if either ultrasound guided core biopsy or fine needle aspiration of an axillary lymph node has superior sensitivity in detecting metastatic carcinoma from the ipsilateral breast.
Primary Outcome
Results of FNA cytology and core biopsy histology are compared to axillary surgery results.
Conditions Studied
Interventions
- PROCEDURE Fine needle aspiration and core biopsy of lymph node
- PROCEDURE Axillary surgery
- OTHER Titanium marker
Study Locations (1)
Pennsylvania
- Magee Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT01920139 record still lists
NCT01920139 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Focus: Breast Cancer With Axillary Node Metastasis appearing as the primary indexed condition, and to 3 interventions - of which Fine needle aspiration and core biopsy of lymph node is the first listed.
NCT01920139 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01920139 about?
NCT01920139 is a clinical study titled "Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy". The study was performed to determine if either ultrasound guided core biopsy or fine needle aspiration of an axillary lymph node has superior sensitivity in detecting metastatic carcinoma from the ipsilateral breast.
What is the current status of trial NCT01920139?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2008-12. Estimated completion is 2011-06.
What conditions does trial NCT01920139 study?
This clinical trial studies the following conditions: Focus: Breast Cancer With Axillary Node Metastasis.
What interventions are being tested in trial NCT01920139?
The interventions under investigation include: Fine needle aspiration and core biopsy of lymph node (PROCEDURE), Axillary surgery (PROCEDURE), Titanium marker (OTHER).
Who is sponsoring clinical trial NCT01920139?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01920139 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01920139's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia